These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 12432440
21. [Clinical characteristics of the white coat hypertension]. Vinyoles E, de la Figuera M. Med Clin (Barc); 1995 Sep 16; 105(8):287-91. PubMed ID: 7475478 [Abstract] [Full Text] [Related]
22. [Frequency of white coat arterial hypertension in mild hypertension. Profile of cardiovascular risk and early organic involvement]. Hernández del Rey R, Armario P, Sánchez P, Castellsague J, Pont F, Cárdenas G, Pardell H. Med Clin (Barc); 1996 May 11; 106(18):690-4. PubMed ID: 8801371 [Abstract] [Full Text] [Related]
23. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care]. Villalba Alcalá F, Lapetra Peralta J, Mayoral Sánchez E, Espino Montoro A, Cayuela Domínguez A, López Chozas JM. Rev Esp Cardiol; 2004 Jul 11; 57(7):652-60. PubMed ID: 15274850 [Abstract] [Full Text] [Related]
24. White coat hypertension in adolescents. Koch VH, Furusawa EA, Saito MI, Colli A, Ignes EC, Okay Y, Mion Júnior D. Clin Nephrol; 1999 Nov 11; 52(5):297-303. PubMed ID: 10584993 [Abstract] [Full Text] [Related]
25. "White coat hypertension" in adolescents: increased values of urinary cortisol and endothelin. Vaindirlis I, Peppa-Patrikiou M, Dracopoulou M, Manoli I, Voutetakis A, Dacou-Voutetakis C. J Pediatr; 2000 Mar 11; 136(3):359-64. PubMed ID: 10700693 [Abstract] [Full Text] [Related]
26. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Int J Cardiol; 2007 May 02; 117(3):355-9. PubMed ID: 16879886 [Abstract] [Full Text] [Related]
27. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group. Babić BK, Bagatin J, Kokić S, Ostojić SB, Carević V, Berović N. Coll Antropol; 2009 Mar 02; 33(1):65-70. PubMed ID: 19408605 [Abstract] [Full Text] [Related]
29. Ambulatory blood pressure characteristics in normotensive and treated hypertensive older people. Wendelin-Saarenhovi ML, Isoaho RE, Hartiala JJ, Helenius HY, Kivelä SL, Löppönen MK, Hietanen EK. J Hum Hypertens; 2002 Mar 02; 16(3):177-84. PubMed ID: 11896507 [Abstract] [Full Text] [Related]
30. The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines. Addison C, Varney S, Coats A. J Hum Hypertens; 2001 Aug 02; 15(8):535-8. PubMed ID: 11494091 [Abstract] [Full Text] [Related]
31. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Sorof JM, Poffenbarger T, Franco K, Portman R. Am J Hypertens; 2001 Sep 02; 14(9 Pt 1):855-60. PubMed ID: 11587149 [Abstract] [Full Text] [Related]
32. The clinical significance of white-coat and masked hypertension. Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, Reboldi G. Blood Press Monit; 2007 Dec 02; 12(6):387-9. PubMed ID: 18277317 [Abstract] [Full Text] [Related]
33. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. Tomiyama M, Horio T, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y. J Hum Hypertens; 2007 Mar 02; 21(3):212-9. PubMed ID: 17167525 [Abstract] [Full Text] [Related]
34. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, Guerrieri M, Comparato E, Porcellati C. Blood Press Monit; 1996 Jun 02; 1(3):217-222. PubMed ID: 10226230 [Abstract] [Full Text] [Related]
35. [Ambulatory blood pressure monitoring in children and adolescents--our results]. Morić VB, Delmis J, Sepec PM. Acta Med Croatica; 2008 Jun 02; 62 Suppl 1():3-6. PubMed ID: 18578325 [Abstract] [Full Text] [Related]
36. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension. Yildiz A, Gür M, Yilmaz R, Demirbağ R, Celik H, Aslan M, Koçyiğit A. Turk Kardiyol Dern Ars; 2008 Jun 02; 36(4):231-8. PubMed ID: 18765966 [Abstract] [Full Text] [Related]
37. Altered cardiovascular rhythmicity in children with white coat and ambulatory hypertension. Litwin M, Simonetti GD, Niemirska A, Ruzicka M, Wühl E, Schaefer F, Feber J. Pediatr Res; 2010 Apr 02; 67(4):419-23. PubMed ID: 20032814 [Abstract] [Full Text] [Related]
38. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring. Ben-Dov IZ, Perk G, Ben-Arie L, Mekler J, Bursztyn M. Am J Hypertens; 2004 Jun 02; 17(6):535-9. PubMed ID: 15177528 [Abstract] [Full Text] [Related]
39. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients. Fogari R, Corradi L, Zoppi A, Lusardi P, Poletti L. Blood Press Monit; 1996 Feb 02; 1(1):51-54. PubMed ID: 10226202 [Abstract] [Full Text] [Related]
40. Out-of-office blood pressure in children and adolescents: disparate findings by using home or ambulatory monitoring. Stergiou GS, Alamara CV, Kalkana CB, Vaindirlis IN, Stefanidis CJ, Dacou-Voutetakis C, Mountokalakis TD. Am J Hypertens; 2004 Oct 02; 17(10):869-75. PubMed ID: 15485747 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]